Percentages of CD62L−CD44+ effector CD8+ T cells were not significantly changed in spleen and TDLN (Figure S5B), but slightly increased in tumor of Eomesfl/+Cd4Cre mice. This evidence concerns the gene CD8A and neoplasm.